14.02.2018 12:00:00

Cyren Reports Fourth Quarter and Full Year 2017 Financial Results

MCLEAN, Va., Feb. 14, 2018 /PRNewswire/ -- Cyren (NASDAQ: CYRN) today announced its fourth quarter and full year 2017 financial results for the period ending December 31, 2017.

During the fourth quarter Cyren received a $19.6 million private placement, priced at $1.85 per share, from Warburg Pincus, a leading global private equity firm focused on growth investing. This was subsequently followed by a tender offer to purchase additional shares at $2.50 per share, which was completed in December, resulting in Warburg Pincus becoming the majority shareholder in Cyren with approximately 52% of the outstanding shares.  "Warburg Pincus identified that Cyren is revolutionizing the cloud security market," said Lior Samuelson, CEO and Chairman of the Board at Cyren. "With Warburg Pincus's financial and operational support, we intend to accelerate our plans to further grow Cyren's Enterprise cloud security business."

"Cyren finished the fourth quarter with solid traction in our Enterprise business, with bookings up 112% compared to the same quarter a year ago," added Samuelson. "Throughout 2017, we added hundreds of new customers onto the Cyren Cloud Security platform, ranging from under 1,000 users to over 100,000 user accounts.  This demonstrates that businesses of all size can benefit from the industry's first and only solution to deliver email security, web security, DNS-based security, cloud sandboxing, and cloud access security all from a single unified SaaS platform."

Earlier in the quarter, Cyren released CCS version 4.2, which adds email archiving to its cloud security platform.  Cyren's archiving service delivers fast search and eDiscovery, tamper-proof storage, and enables regulatory compliance with email management, protection and retention in the cloud.

Fourth Quarter 2017 Financial Highlights:

  • Revenues for the fourth quarter of 2017 were $7.5 million, compared to $8.1 million for the fourth quarter of 2016.
  • Revenues for the year ended December 31, 2017 were $30.8 million compared to $31.0 million for fiscal year 2016.
  • GAAP net loss for the fourth quarter of 2017 was $7.5 million, compared to a net loss of $2.9 million in the fourth quarter of 2016. The net loss for the fourth quarter included a one-time impact of approximately $2.9 million due to the accounting treatment of employee stock options and convertible notes triggered by a change of control provision when Warburg Pincus became the majority shareholder in Cyren.
  • GAAP net loss for the year ended December 31, 2017 was $16.3 million, compared to $6.2 million for 2016.
  • GAAP loss per basic and diluted share for the fourth quarter of 2017 was $0.16, compared to a loss of $0.07 for the fourth quarter of 2016. For the full year 2017, GAAP loss per basic and diluted share was $0.40, compared to a loss of $0.16 for full year 2016.
  • Non-GAAP net loss for the fourth quarter of 2017 was $4.3 million, compared to a Non-GAAP net loss of $1.9 million for the fourth quarter of 2016.
  • Non-GAAP loss per basic and diluted share was $0.09 for the fourth quarter of 2017, compared to a Non-GAAP loss of $0.05 in fourth quarter of 2016. Non-GAAP loss per basic and diluted share was $0.30 for full year 2017, compared to $0.12 during full year 2016.
  • Cash balance as of December 31, 2017 was $24.0 million, compared to $10.6 million as of December 31, 2016. The cash balance at year end includes net proceeds from the Warburg Pincus private placement which closed in November. Moving forward, Cyren expects to make additional investments in R&D, Sales and Marketing in order to accelerate our product roadmap and increase enterprise sales throughout 2018.
  • The convertible notes, previously on the balance sheet since being issued in March 2017, were automatically converted into approximately 3.5 million shares upon the completion of the Warburg Pincus tender offer. At year end, Cyren had approximately 53.4 million shares outstanding, and currently has no outstanding debt.

For information regarding the non-GAAP financial measures discussed in this release, please see "Use of Non-GAAP Financial Measures" and "Reconciliation of Selected GAAP Measures to Non-GAAP Measures."

Recent Business Highlights:

  • At the company's annual shareholder meeting in December, all resolutions on the proxy were approved, including the re-election of five continuing directors and the formal approval of two new directors. Cyren's board of directors is now comprised of nine directors, including Cary Davis and Brian Chang, both of whom joined the board from Warburg Pincus.
  • During the third and fourth quarters, Cyren added a number of new distribution and reseller partners for its Enterprise business in the US and Europe. Most recently Cyren announced the addition of CARVIR, a global cyber security company with over 500 MSP partners, and a leader in monitored and managed security for the MSP and IT Services channel.
  • During the fourth quarter, Cyren renewed and increased several contracts for Cyren's Threat Intelligence Services using Cyren's embedded email security, web security, and cyber intelligence solutions. For the year, Cyren experienced higher than expected turnover in its Threat Intelligence business, most notably from a few large clients whose contracts were terminated earlier in the year.

Financial Results Conference Call:

The company will host a conference call at 10 a.m. Eastern Time (5 p.m. Israel Time) on Wednesday, February 14, 2018.

U.S. Dial-in Number:

1-800-239-9838

Israel Dial-in Number:

1-80-921-2883

International Dial-in Number:

1-323-794-2551

The call will be simultaneously webcast live on the investor relations section of Cyren's website at http://ir.cyren.com, or by using the following link: http://public.viavid.com/index.php?id=128245.

For those unable to participate in the live conference call, a replay will be available until February 28, 2018. To access the replay, the U.S. dial in number is 1-844-512-2921 and the non-U.S. dial in number is 1-412-317-6671. Callers will be prompted for replay conference ID number 5306817. An archived version of the webcast will also be available on the investor relations section of the company's website at http://ir.cyren.com/events.

About Cyren:

More than 1.3 billion users around the world rely on Cyren's 100% cloud internet security solutions to protect them against cyber attacks and data loss every day. Powered by the world's largest security cloud, Cyren (NASDAQ and TASE: CYRN) delivers fast time to protection from cyber threats with award-winning security as a service for web, email, sandboxing, and DNS for enterprises, and embedded threat intelligence solutions for security vendors and service providers. Customers like Google, Microsoft and Check Point are just a few of the businesses that depend on Cyren every day to power their security. Learn more at www.cyren.com.

Blog: http://blog.cyren.com
Facebook: www.facebook.com/CyrenWeb
LinkedIn: www.linkedin.com/company/cyren
Twitter: www.twitter.com/CyrenInc

Use of Non-GAAP Financial Measures:

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: stock-based compensation expenses, amortization of acquired intangible assets, executive termination costs, deferred taxes and deferred revenues related to acquisitions, one-time gain from sale of investment in affiliate, adjustments to earn-out obligations, capitalization of technology, accretion of discount on convertible note and change in fair value of the embedded conversion feature. The purpose of such adjustments is to give an indication of the company's performance exclusive of non-cash charges and other items that are considered by management to be outside of the company's core operating results. The company's non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with the company's consolidated financial statements prepared in accordance with GAAP.

Company management regularly uses supplemental non-GAAP financial measures internally to understand, manage and evaluate the business and make operating decisions.

These non-GAAP measures are among the primary factors management uses in planning for and forecasting future periods. The company believes this adjustment is useful to investors as a measure of the ongoing performance of the business. The company believes these non-GAAP financial measures provide consistent and comparable measures to help investors understand the company's current and future operating cash flow performance. These non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table immediately following the Consolidated Statements of Income. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management uses both GAAP and non-GAAP measures when evaluating the business internally and therefore felt it important to make these non-GAAP adjustments available to investors.

This press release contains forward-looking statements, including projections about the company's business, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. For example, statements in the future tense, and statements including words such as "expect," "plan," "estimate," "anticipate," or "believe" are forward-looking statements. These statements are based on information available at the time of the press release and the company assumes no obligation to update any of them. The statements in this press release are not guarantees of future performance and actual results could differ materially from current expectations as a result of numerous factors, including business conditions and growth or deterioration in the internet security market, technological developments, products offered by competitors, availability of qualified staff, and technological difficulties and resource constraints encountered in developing new products, as well as those risks described in the company's Annual Reports on Form 20-F and reports on Form 6-K, which are available through www.sec.gov.

Company Contact
Mike Myshrall, CFO
Cyren
+1.703.760.3320
mike.myshrall@cyren.com

Israel Investor Contact
Iris Lubitch
SmarTeam
+972.54.2528007
iris@smartteam.co.il 

Media Contact
Matthew Zintel
Zintel Public Relations
+1.281.444.1590
matthew.zintel@zintelpr.com 

 

CYREN LTD.









 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in  thousands of U.S. dollars, except per share amounts)










Three months ended 


Twelve months ended 


December 31


December 31


2017


2016


2017


2016


Unaudited


Unaudited


Unaudited


Audited









 Revenues 

$    7,522


$    8,111


$  30,799


$30,983









 Cost of revenues 

3,461


2,682


12,584


10,042









Gross profit 

4,061


5,429


18,215


20,941

















Operating expenses:
















 Research and development, net

2,896


2,203


9,825


8,656









 Sales and marketing 

4,156


3,512


15,551


10,814









 General and administrative 

2,313


1,782


7,286


6,645









 Adjustment of earn-out obligation

-


893


-


893









 Total operating expenses 

9,365


8,390


32,662


27,008









Operating loss

(5,304)


(2,961)


(14,447)


(6,067)









Other income (expense)

1


(6)


452


(1)









Financial income (expense), net 

(2,117)


54


(2,380)


(147)









Loss before taxes

(7,420)


(2,913)


(16,375)


(6,215)









Tax benefit (expense)

(106)


9


42


2

















Net loss

$  (7,526)


$  (2,904)


$(16,333)


$ (6,213)

















Loss per share - basic

$    (0.16)


$    (0.07)


$     (0.40)


$   (0.16)









Loss per share - diluted 

$    (0.16)


$    (0.07)


$     (0.40)


$   (0.16)









Weighted average number of shares outstanding: 








Basic 

46,018


39,167


40,922


39,135









Diluted  

46,018


39,167


40,922


39,135

 

CYREN LTD.









RECONCILIATION OF SELECTED GAAP MEASURES TO NON-GAAP MEASURES

(in  thousands of U.S.dollars, except per share amounts)










Three months ended 


Twelve months ended 


December 31


December 31


2017


2016


2017


2016


Unaudited


Unaudited


Unaudited


Unaudited









GAAP operating loss

$  (5,304)


$  (2,961)


$(14,447)


$  (6,067)

Stock-based compensation (1)

1,251


233


2,060


980

Amortization of intangible assets (2)

1,139


790


4,431


2,836

Adjustment to earn-out liabilities and related expenses (3)

-


893


-


893

Executive terminations (5)

-


-


-


87

Adjustment to deferred revenues (6)

-


-


-


66

Capitalization of technology (8)

(1,012)


(852)


(3,728)


(3,097)

Non-GAAP operating loss

$  (3,926)


$  (1,897)


$(11,684)


$  (4,302)









GAAP net loss

$  (7,526)


$  (2,904)


$(16,333)


$  (6,213)

Stock-based compensation (1)

1,251


233


2,060


980

Amortization of intangible assets (2)

1,139


790


4,431


2,836

Adjustment to earn-out liabilities and related expenses (3)

26


893


117


893

Amortization of deferred tax assets (4)

(63)


(62)


(249)


(278)

Executive terminations (5)

-


-


-


87

Adjustment to deferred revenues (6)

-


-


-


66

Gain from sale of investment in affiliate (7)

-


-


(450)


-

Capitalization of technology (8)

(1,057)


(852)


(3,822)


(3,128)

Accretion of discount on convertible note (9)

150


-


480


-

Change in fair value of embedded conversion feature on convertible note (10)

1,814


-


1,349


-

Non-GAAP net loss

$  (4,266)


$  (1,902)


$(12,417)


$  (4,757)









GAAP loss per share (diluted)

$    (0.16)


$    (0.07)


$     (0.40)


$    (0.16)

Stock-based compensation (1)

0.03


0.00


0.05


0.03

Amortization of intangible assets (2)

0.02


0.02


0.11


0.07

Adjustment to earn-out liabilities and related expenses (3)

0.00


0.02


0.00


0.02

Amortization of deferred tax assets (4)

(0.00)


(0.00)


(0.00)


0.00

Executive terminations (5)

0.00


0.00


0.00


0.00

Adjustment to deferred revenues (6)

0.00


0.00


0.00


0.00

Gain from sale of investment in affiliate (7)

0.00


0.00


(0.01)


0.00

Capitalization of technology (8)

(0.02)


(0.02)


(0.09)


(0.08)

Accretion of discount on convertible note (9)

0.00


0.00


0.01


0.00

Change in fair value of embedded conversion feature on convertible note (10)

0.04


0.00


0.03


0.00

Non-GAAP loss per share (diluted)

$    (0.09)


$    (0.05)


$     (0.30)


$    (0.12)









Numbers of shares used in computing non-GAAP loss per share (diluted)

46,018


39,167


40,922


39,125









(1) Stock-based compensation 








Cost of revenues 

$       131


$         22


$       207


$         73

Research and development 

277


71


505


314

Sales and marketing 

373


45


553


198

General and administrative 

470


95


795


395


$    1,251


$       233


$    2,060


$       980









(2) Amortization of intangible assets 








Cost of revenues 

$       971


$       610


$    3,756


$    2,090

Sales and marketing 

168


180


675


746


$    1,139


$       790


$    4,431


$    2,836









(3) Adjustment to earn-out liabilities and related expenses








General and administrative 

$            -


$       893


$            -


$       893

Financial expenses, net 

26


-


117


-


$         26


$       893


$       117


$       893









(4) Amortization of deferred tax assets








Tax benefit (expense)

$        (63)


$        (62)


$      (249)


$     (278)









(5) Executive terminations 








Sales and marketing 

$            -


$            -


$            -


$         87









(6) Adjustment to deferred revenues 








Revenues

$            -


$            -


$            -


$         66









(7) Gain from sale of investment in affiliate








Other Income

$            -


$            -


$      (450)


$            -









(8) Capitalization of technology








Research and development

$  (1,012)


$     (852)


$  (3,728)


$  (3,097)

Financial expenses, net 

(45)


-


(94)


(31)


$  (1,057)


$     (852)


$  (3,822)


$  (3,128)









(9) Accretion of discount on convertible note








Financial expenses, net 

$       150


$            -


$       480


$            -









(10) Change in fair value of embedded conversion feature on convertible note








Financial expenses, net 

$    1,814


$            -


$    1,349


$            -

 

CYREN LTD.





CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands of U.S. dollars)






December 31


December 31


2017


2016


Unaudited


Audited





Assets




    Current Assets:




Cash and cash equivalents 

$           23,981


$           10,621

Trade receivables, net

2,890


3,061

Prepaid expenses and other receivables

1,339


918

 Total current assets 

28,210


14,600





Property and equipment, net 

2,787


2,081

Goodwill and intangible assets, net

31,461


29,867

Severance pay fund 

714


604

Lease deposits 

379


380

 Total long-term assets 

35,341


32,932

Total assets

$           63,551


$           47,532









Liabilities and Shareholders' Equity




    Current Liabilities:




Trade payables

$             1,017


$                764

Employees and payroll accruals 

3,239


2,528

Accrued expenses and other liabilities 

1,012


755

Earn-out consideration

3,588


3,041

Deferred revenues

5,032


4,609

 Total current liabilities 

13,888


11,697





Deferred revenues

524


1,788

Deferred tax liability

1,355


1,374

Accrued severance pay 

930


816

Other liabilities

438


119

Total long-term liabilities

3,247


4,097





Shareholders' equity 

46,416


31,738

Total liabilities and shareholders' equity

$           63,551


$           47,532

 

CYREN LTD.









 CONDENSED CONSOLIDATED CASH FLOW DATA

(in thousands of U.S. dollars)










Three months ended 


Twelve months ended 


December 31


December 31


2017


2016


2017


2016

Cash flows from operating activities:

Unaudited


Unaudited


Unaudited


Audited









Net loss

$   (7,526)


$   (2,904)


$ (16,333)


$ (6,213)









Adjustments to reconcile net loss to net cash provided by (used in) operating activities:








Loss on disposal of property and equipment

1


8


2


11

Depreciation 

437


291


1,303


1,246

Stock-based compensation

1,251


233


2,060


980

Amortization of intangible assets

1,139


790


4,431


2,836

Accrued interest and accretion of discount on credit line

-


-


-


(19)

Accretion of discount on convertible note

150


-


480


-

Change in fair value of embedded conversion feature on convertible note

1,814


-


1,349


-

Other income related to investment in affiliate

-


-


(450)


-

Other expenses related to the earn-out consideration

26


774


117


774

Deferred taxes

(29)


(35)


(175)


(212)









Changes in assets and liabilities:








Trade receivables

(291)


642


77


759

Prepaid expenses and other receivables

284


(37)


(362)


(82)

Change in long-term lease deposits

118


77


6


(184)

Trade payables

(45)


111


36


124

Employees and payroll accruals, accrued expenses and other liabilities

578


282


1,035


16

Deferred revenues

(1,085)


(1,039)


(841)


2,305

Accrued severance pay, net

(62)


33


4


88

Other long-term liabilities

302


(8)


302


(11)

Net cash provided by (used in) operating activities

(2,938)


(782)


(6,959)


2,418









Cash flows from investing activities:
















Proceeds from sale of investment in affiliate

-


-


450


-

Capitalization of technology, net of grants received

(1,057)


(852)


(3,822)


(3,128)

Purchase of property and equipment

(953)


(137)


(1,771)


(985)

Net cash used in investing activities

(2,010)


(989)


(5,143)


(4,113)









Cash flows from financing activities:
















Proceeds from convertible note

-


-


6,300


-

Proceeds from private capital raise

18,971


-


18,971


-

Payment of credit line

-


-


-


(4,150)

Proceeds from options exercised

18


13


93


84

Net cash provided by (used in) financing activities

18,989


13


25,364


(4,066)

Effect of exchange rate changes on cash

21


(59)


98


3

Increase (decrease) in cash and cash equivalents

14,062


(1,817)


13,360


(5,758)

Cash and cash equivalents at the beginning of the period

9,919


12,438


10,621


16,379

Cash and cash equivalents at the end of the period

$  23,981


$  10,621


$  23,981


$10,621

 

CYREN Logo. (PRNewsFoto/CYREN)

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/cyren-reports-fourth-quarter-and-full-year-2017-financial-results-300598204.html

SOURCE Cyren

Nachrichten zu Cyrenmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Cyrenmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Cyren 0,00 0,00% Cyren